Myasthenia gravis is an autoimmune disease of neuromuscular junctions, in which autoantibodies against acetylcholine receptors, MuSK and LRP4 have been observed in approximately 85%, 5%, and 2% of patients with myasthenia gravis, respectively47. This evidence concerns the gene LRP4 and myasthenia gravis.